Distinction Between Recurrent Glioma and Radiation Injury Using Magnetic Resonance Spectroscopy in Combination With Diffusion-Weighted Imaging

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 1, 2007, Pages 151-158

  Zeng, Qing Shi ^a   Li, Chuan Fu ^a   Liu, Hong ^a   Zhen, Jun Hui ^a   Feng, De Chao ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Glioma; Magnetic resonance imaging; Magnetic resonance spectroscopy; Neoplasm recurrence; Radiotherapy

Indexed keywords

BRAIN; DIFFUSION; HISTOLOGY; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; PATHOLOGY; PATIENT MONITORING; RADIOTHERAPY; SPECTROSCOPIC ANALYSIS; TUMORS;

DIFFUSION-WEIGHTED IMAGING; GLIOMAS; HISTOPATHOLOGY; MR SPECTROSCOPY; N-ACETYLASPARTATE (NAA); NEOPLASM RECURRENCE;

ONCOLOGY;

CHOLINE; CREATININE; GADOLINIUM PENTETATE; LACTIC ACID; LIPID; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RADIATION INJURY; TUMOR RECURRENCE;

ADULT; AGED; ASPARTIC ACID; BRAIN; BRAIN NEOPLASMS; CHOLINE; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; DISCRIMINANT ANALYSIS; FEMALE; GLIOMA; HUMANS; LACTIC ACID; LIPID METABOLISM; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOSPHOCREATINE; RADIATION INJURIES;

EID: 34247144989     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.12.001     Document Type: Article

References (20)

1. Mullins M.E., Barest G.D., Schaefer P.W., et al. Radiation necrosis versus glioma recurrence: Conventional MR imaging clues to diagnosis. Am J Neuroradiol 26 (2005) 1967-1972
2. Kumar A.J., Leeds N.E., Fuller G.N., et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 217 (2000) 377-384
3. Hein P.A., Eskey C.J., Dunn J.F., et al. Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: Tumor recurrence versus radiation injury. Am J Neuroradiol 25 (2004) 201-209
4. Asao C., Korogi Y., Kitajima M., et al. Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. Am J Neuroradiol 26 (2005) 1455-1460
5. Weybright P., Sundgren P.C., Maly P., et al. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy. Am J Roentgenol 185 (2005) 1471-1476
6. Schlemmer H.P., Bachert P., Henze M., et al. Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy. Neuroradiology 44 (2002) 216-222
7. Schlemmer H.P., Bachert P., Herfarth K., et al. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. Am J Neuroradiol 22 (2001) 1316-1324
8. Rabinov J.D., Lee P.L., Barker F.G., et al. In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: Initial experience. Radiology 225 (2002) 871-879
9. McKnight T.R., von dem Bussche M.H., Vigneron D.B., et al. Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 97 (2002) 794-802
10. Lichy M.P., Plathow C., Schulz-Ertner D., et al. Follow-up gliomas after radiotherapy: 1H MR spectroscopic imaging for increasing diagnostic accuracy. Neuroradiology 47 (2005) 826-834
11. Castillo M., Smith J.K., Kwock L., et al. Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. Am J Neuroradiol 22 (2001) 60-64
12. Lam W.W., Poon W.S., and Metreweli C. Diffusion MR imaging in glioma: Does it have any role in the pre-operation determination of grading of glioma?. Clin Radiol 57 (2002) 219-225
13. Tsui E.Y., Chan J.H., Ramsey R.G., et al. Late temporal lobe necrosis in patients with nasopharyngeal carcinoma: Evaluation with combined multi-section diffusion weighted and perfusion weighted MR imaging. Eur J Radiol 39 (2001) 133-138
14. Kreth F.W., Berlis A., Spiropoulou V., et al. The role of tumor resection in the treatment of glioblastoma multiforme in adults. Cancer 86 (1999) 2117-2123
15. Herfarth K.K., Gutwein S., and Debus J. Postoperative radiotherapy of astrocytomas. Semin Surg Oncol 20 (2001) 13-23
16. Kallen K., Burtscher I.M., Holtas S., et al. 201Thallium SPECT and 1H-MRS compared with MRI in chemotherapy monitoring of high-grade malignant astrocytomas. J Neurooncol 46 (2000) 173-185
17. Kono K., Inoue Y., Nakayama K., et al. The role of diffusion-weighted imaging in patients with brain tumors. Am J Neuroradiol 22 (2001) 1081-1088
18. Rock J.P., Scarpace L., Hearshen D., et al. Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis. Neurosurgery 54 (2004) 1111-1117
19. Bammer R. Basic principles of diffusion-weighted imaging. Eur J Radiol 45 (2003) 169-184
20. McGirt M.J., Woodworth G.F., Coon A.L., et al. Independent predictors of morbidity after image-guided stereotactic brain biopsy: A risk assessment of 270 cases. J Neurosurg 102 (2005) 897-901